A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer
2013 ◽
Vol 73
(1)
◽
pp. 163-169
◽
Keyword(s):
Phase Ii
◽